Şükriye Uslu

Dr. Şükriye Uslu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
AAAdnan Abaci
Adnan Abaci
MYMurat Gökhan YERLİKAYA
Murat Gökhan YERLİKAYA
TKTuğba Kapanşahin
Tuğba Kapanşahin
GSGöktuğ Savaş
Göktuğ Savaş
AAAli Rıza Akyüz
Ali Rıza Akyüz
HAHasan Ari
Hasan Ari
BACKGROUND: Isolated coronary artery ectasia (CAE) is a less common form of CAE. The clinical significance of isolated CAE has not been elucidated yet. We aimed to compare the patients with myocardial infarction (MI) due to isolated CAE with the patients without CAE. METHODS: We retrospectively included patients who underwent coronary angiography with a diagnosis of first MI caused by isolated CAE. We excluded patients with >20% stenosis in any vessel other than the lesion responsible for the MI. A second group of patients with MI without CAE was selected as the control group. The primary outcome was the composite of all-cause death and nonfatal recurrent MI occurring after index hospitalization. RESULTS: A total of 404 patients were included. Overall, 63.9% of MIs were ST-elevation MI. Almost all patients in the isolated CAE group had multivessel diffuse ectasia, with 71.3% classified as Markis I, and 26.7% as Markis II. Death or MI recurrence occurred in 54 (26.7%) patients in the isolated CAE group and 33 (16.3%) patients in the control group ( P =0.011). Death occurred in 8 (4.0%) patients in the isolated CAE group versus 6 (3.0%) patients in the control group; recurrent MI in 46 (22.8%) versus 27 (13.4%) patients, respectively. Stent thrombosis was more common in the CAE group compared with the control group (8.9% versus 1.5%; P <0.001). In multiple variable analysis, the presence of CAE was associated with death/recurrent MI (hazard ratio, 1.84 [95% CI, 1.11–3.05]; P =0.017), and recurrent MI (hazard ratio, 2.07 [95% CI, 1.08–3.96]; P =0.029). CONCLUSIONS: The patients with MI due to isolated CAE had a higher risk of recurrent MI and stent thrombosis compared with the patients without CAE. In this study, the rate of recurrent MI from the index infarct artery was also higher in the patients with CAE.

3 August 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
SASakir Arslan
Sakir Arslan
NBNermin Bayar
Nermin Bayar
ŞUŞükriye Uslu
Şükriye Uslu
ATAntalya- Turkey
Antalya- Turkey

18 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ŞUŞükriye Uslu
Şükriye Uslu
GÖGülsüm Meral Yılmaz Öztekin
Gülsüm Meral Yılmaz Öztekin
Background/Objectives: Many patients with acute coronary syndrome (ACS) fail to achieve adequate low-density lipoprotein-cholesterol (LDL-C) reduction, despite receiving high-intensity statin therapy. Identifying patients requiring early combination therapy remains a challenging task. This study aimed to determine the prevalence of statin hyporesponsiveness in patients with ACS and investigate the predictive role of baseline LDL-C and albumin levels. Methods: This retrospective study enrolled 366 patients with ACS treated with high-intensity statins (atorvastatin 40–80 mg). Hyporesponsiveness was defined as LDL-C reduction of <50% at 21–28 d. The baseline parameters were analyzed using logistic regression and receiver operating characteristic (ROC) curve analysis. Results: Hyporesponsiveness was observed in 63.1% of patients. Hyporesponders had significantly lower baseline albumin (41.7 vs. 43.3 g/L, p = 0.0002) and LDL-C (126.6 vs. 147.3 mg/dL, p < 0.0001) levels. Categorical analysis revealed that the combination of baseline LDL-C < 100 mg/dL and albumin < 40 g/L predicted hyporesponsiveness in 95.7% of cases. ROC curve analysis identified optimal predictive cut-offs of 128.50 mg/dL for LDL-C (area under the curve (AUC): 0.652) and 41.15 g/L for albumin (AUC: 0.618). The combined LDL-C + albumin model demonstrated superior predictive performance with an AUC of 0.670 (95% CI: 0.615–0.725). Conclusions: Low baseline LDL-C and low albumin are strong predictors of statin hyporesponsiveness in patients with ACS. These routinely obtained biomarkers can identify very high-risk patients who may benefit from proactive combination lipid-lowering therapy from hospital discharge, supporting the “strike early and strike strong” strategy and challenging the traditional stepwise approach.

3 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ŞUŞükriye Uslu
Şükriye Uslu
GÖGülsüm Meral Yılmaz Öztekin
Gülsüm Meral Yılmaz Öztekin
Background/Objectives: Many patients with acute coronary syndrome (ACS) fail to achieve adequate low-density lipoprotein-cholesterol (LDL-C) reduction, despite re-ceiving high-intensity statin therapy. Identifying patients requiring early combination therapy remains a challenging task. This study aimed to determine the prevalence of statin hyporesponsiveness in patients with ACS and investigate the predictive role of baseline LDL-C and albumin levels. Methods: This retrospective study enrolled 366 pa-tients with ACS treated with high-intensity statins (atorvastatin 40–80 mg). Hyporesponsiveness was defined as LDL-C reduction of < 50% at 21–28 d. The baseline parameters were analyzed using logistic regression and receiver operating characteris-tic (ROC) curve analysis. Results: Hyporesponsiveness was observed in 63.1% of pa-tients. Hyporesponders had significantly lower baseline albumin (41.7 vs. 43.3 g/L, p=0.0002) and LDL-C (126.6 vs 147.3 mg/dL, p< 0.0001) levels. Categorical analysis re-vealed that the combination of baseline LDL-C < 100 mg/dL and albumin < 40 g/L pre-dicted hyporesponsiveness in 95.7% of cases. ROC curve analysis identified optimal predictive cut-offs of 128.50 mg/dL for LDL-C (AUC: 0.652) and 41.15 g/L for albumin (AUC: 0.618). Conclusions: Low baseline LDL-C and low albumin are strong predictors of statin hyporesponsiveness in patients with ACS. These routinely obtained bi-omarkers can identify very high-risk patients who may benefit from proactive combi-nation lipid-lowering therapy from hospital discharge, supporting the "strike early and strike strong" strategy and challenging the traditional stepwise approach.

Verified
Journal Article
Open access
PDF file
Oguz kaan KayaOguz kaan Kaya
Oguz kaan Kaya
ŞUŞükriye Uslu
Şükriye Uslu
Background: Non-invasive biomarkers may facilitate early risk stratification in patients with coronary artery disease (CAD). Although the uric acid-to-HDL cholesterol ratio (UHR) has been identified as a novel marker associated with coronary atherosclerosis, the relationship between the uric acid-to-magnesium ratio (UA/Mg ratio) and the angiographic burden of coronary artery disease has not been sufficiently investigated. This study evaluated the association between the UA/Mg ratio and angiographic coronary artery disease burden in patients undergoing elective coronary angiography and compared its discriminative performance with that of the UHR and the frontal QRS-T angle. Methods: In this retrospective cross-sectional study, patients who underwent elective coronary angiography between 2022 and 2025 were evaluated. Patients with atrial fibrillation, left ventricular ejection fraction <50%, eGFR < 50 mL/min/1.73 m2, severe valvular disease, uric acid-lowering therapy, or acute coronary syndrome were excluded. A total of 351 patients were included in the study and divided into three groups—low (n = 117), intermediate (n = 117), and high (n = 117)—based on their Gensini scores. Independent associations were evaluated using multivariable ordinal logistic regression analysis. Receiver operating characteristic (ROC) analysis was performed to evaluate discrimination of the high Gensini tertile. Results: The UA/Mg ratio was strongly correlated with the Gensini score (ρ = 0.699, p < 0.001), showing a correlation comparable to that of the UHR (ρ = 0.717, p < 0.001) and stronger than that of the frontal QRS-T angle (ρ = 0.546, p < 0.001). In the multivariable ordinal logistic regression analysis, the UA/Mg ratio remained independently associated with higher Gensini tertiles (OR = 2.34, 95% CI: 1.23–4.45; p = 0.009). In the ROC analysis, the UA/Mg ratio demonstrated excellent discriminative performance for identifying the high Gensini tertile (AUC = 0.907, 95% CI: 0.877–0.938). The AUC of the UA/Mg ratio was comparable to that of the UHR (DeLong p = 0.978), whereas it was significantly higher than that of the frontal QRS-T angle (DeLong p < 0.001). Conclusions: The uric acid-to-magnesium ratio was strongly and independently associated with the burden of angiographic coronary artery disease in patients undergoing elective coronary angiography. The UA/Mg ratio demonstrated discriminative performance comparable to that of the UHR and superior to the frontal QRS-T angle. These findings suggest that the UA/Mg ratio may serve as a complementary biomarker for assessing angiographic coronary artery disease burden. Further prospective studies are warranted to validate its clinical utility.

ŞUŞükriye Uslu
Şükriye Uslu
GÖGülsüm Meral Yılmaz Öztekin
Gülsüm Meral Yılmaz Öztekin
AGAhmet Genç
Ahmet Genç
EÇEkin Can Çelik
Ekin Can Çelik
ŞAŞakir Arslan
Şakir Arslan
Background: This study investigated the role of lymphocyte-based inflammatory indices (LBIIs) in predicting severe coronary artery disease (CAD) in patients undergoing coronary angiography (CAG) for unstable angina pectoris (USAP). Methods: Records of patients who underwent CAG between January 2023 and December 2024 were retrospectively reviewed. The patients were divided into two groups based on coronary artery stenosis severity: non-severe CAD (<70% stenosis) and severe CAD (≥70% stenosis). Demographic data, risk factors, and complete blood count parameters were recorded. Six LBIIs were calculated: the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), Systemic Immune–Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Systemic Immune–Inflammatory Response Index (SIIRI). Diagnostic performance was evaluated using logistic regression and ROC curve analyses. Results: Out of 505 patients, 234 (46.3%) had severe CAD. Among the six LBIIs, only the SII differed significantly between groups in univariate analysis and showed moderate discrimination in the ROC analysis (AUC 0.71; 95% CI 0.661–0.762; p < 0.001; sensitivity 76.2%; specificity 56.1%). However, the SII was not an independent predictor in the multivariate analysis. Conclusions: LBIIs (NLR, MLR, PLR, SII, SIRI, and SIIRI) do not provide a clinically significant and independent contribution to predicting severe CAD in USAP patients undergoing CAG. Although the SII performed moderately well in the univariate analysis, it lost independence in the multivariate analysis and is thus not suitable for use as a standalone marker in clinical decision-making.